Used as a key intermediate in Suzuki-Miyaura cross-coupling reactions, enabling the synthesis of complex organic molecules, particularly in pharmaceutical and agrochemical industries. Its boronate ester group facilitates efficient carbon-carbon bond formation under mild conditions, making it valuable in the development of active pharmaceutical ingredients (APIs) and functional materials. The presence of fluorinated aryl groups enhances metabolic stability and lipophilicity in drug candidates, improving bioavailability and target binding. Commonly employed in late-stage functionalization due to its stability and reactivity profile.